FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. Pinnacle Professional Research dba Pinnacle Peptides

    FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.

    High risk
  2. Zhejiang Huahai Pharmaceutical Co., Ltd.

    FDA warns Zhejiang Huahai Pharmaceutical over CGMP violations including dirty equipment, aseptic-area tape, and data integrity issues.

    High risk
  3. Intercos Europe S.p.A

    FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.

    High risk
  4. Westwood Laboratories LLC

    FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.

    High risk
  5. Maggie Jeffries, M.D. / Avanti Anesthesiology, LLC

    FDA warns Houston clinical investigator Dr. Maggie Jeffries for running drug trials without an IND and with informed-consent failures.

    High risk
  6. globalpharmacyplus.com

    FDA warned globalpharmacyplus.com in Canada for selling unapproved and misbranded prescription drugs to U.S. consumers online.

    High risk
  7. Toyobo Co. Ltd.

    FDA warned Toyobo after inspection found unresolved particulate contamination and environmental monitoring data manipulation affecting sterile injectable drugs.

    High risk